These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29936931)

  • 1. LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice.
    Park JG; Jeong SJ; Yu J; Kim G; Jeong LS; Oh GT
    BMB Rep; 2018 Oct; 51(10):520-525. PubMed ID: 29936931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis.
    Lee J; Hwang I; Lee JH; Lee HW; Jeong LS; Ha H
    Am J Pathol; 2013 Nov; 183(5):1488-1497. PubMed ID: 24001475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.
    Xu J; Zhu L; Liu H; Li M; Liu Y; Yang F; Pei Z
    Lipids Health Dis; 2018 Jul; 17(1):173. PubMed ID: 30049280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO.
    Lecanu L; Yao ZX; McCourty A; Sidahmed el-K; Orellana ME; Burnier MN; Papadopoulos V
    Steroids; 2013 Feb; 78(2):137-46. PubMed ID: 23182766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
    Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
    J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50.
    Fang G; Song D; Ye X; Mao SZ; Liu G; Liu SF
    Am J Pathol; 2012 Nov; 181(5):1530-9. PubMed ID: 22940439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of endothelin receptors reduces diet-induced hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice.
    Iwasa S; Fan J; Miyauchi T; Watanabe T
    Pathobiology; 2001; 69(1):1-10. PubMed ID: 11641611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LJ-529, a partial peroxisome proliferator-activated receptor gamma (PPARγ) agonist and adenosine A
    Boo HJ; Park SJ; Noh M; Min HY; Jeong LS; Lee HY
    Arch Pharm Res; 2020 May; 43(5):540-552. PubMed ID: 32430718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells.
    Ryu HM; Kim YJ; Oh EJ; Oh SH; Choi JY; Cho JH; Kim CD; Park SH; Kim YL
    J Cell Mol Med; 2016 Nov; 20(11):2160-2172. PubMed ID: 27396856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanidin-3-O-β-glucoside upregulates hepatic cholesterol 7α-hydroxylase expression and reduces hypercholesterolemia in mice.
    Wang D; Xia M; Gao S; Li D; Zhang Y; Jin T; Ling W
    Mol Nutr Food Res; 2012 Apr; 56(4):610-21. PubMed ID: 22495986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
    Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
    Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterol 27-hydroxylase gene dosage and the antiatherosclerotic effect of Rifampicin in mice.
    Zurkinden L; Sviridov D; Vogt B; Escher G
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29191818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.
    Dong P; Pan L; Zhang X; Zhang W; Wang X; Jiang M; Chen Y; Duan Y; Wu H; Xu Y; Zhang P; Zhu Y
    J Ethnopharmacol; 2017 Feb; 198():479-488. PubMed ID: 28119096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe
    Romano G; Reggi S; Kutryb-Zajac B; Facoetti A; Chisci E; Pettinato M; Giuffrè MR; Vecchio F; Leoni S; De Giorgi M; Avezza F; Cadamuro M; Crippa L; Leone BE; Lavitrano M; Rivolta I; Barisani D; Smolenski RT; Giovannoni R
    Int J Cardiol; 2018 Nov; 271():233-239. PubMed ID: 29907443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
    Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
    Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E
    Rinne P; Kadiri JJ; Velasco-Delgado M; Nuutinen S; Viitala M; Hollmén M; Rami M; Savontaus E; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):313-323. PubMed ID: 29284608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.